Proton Beam Radiation Therapy for Skull Base Adenoid Cystic Carcinoma.
Author: Pommier P, Liebsch NJ, Deschler DG, et al.
Journal: Arch Otolaryngol Head Neck Surg.
Edition: 132(11): 1242-9.
Issued Date: 2006.
Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Author: Pehlivan B, Ares C, Lomax AJ, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 83(5):1432-1440.
Issued Date: 2012.
Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams..
Author: Noel G, Feuvret L, Calugaru V, et al.
Journal: Acta Oncol.
Edition: 44(7):700-8.
Issued Date: 2005.
Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Author: Pehlivan B, Ares C, Lomax AJ et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 83(5):1432-40.
Issued Date: 2012.
Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Author: Santoni R, Liebsch N, Finkelstein DM et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 41(1):59-68.
Issued Date: 1998.
Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Author: Hug EB, Loredo LN, Slater JD et al.
Journal: J Neurosurg.
Edition: 91(3):432-9.
Issued Date: 1999.
A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
Author: Feuvret L, Noel G, Weber DC et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 69(3):944-54.
Issued Date: 2007.
Spot-scanning-based proton therapy for extracranial chordoma.
Author: Staab A, Rutz HP, Ares C, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 81(4):e489-96.
Issued Date: 2011.
Chordoma of the spinal column.
Author: Sciubba DM, Chi JH, Rhines LD, et al.
Journal: Neurosurg Clin N Am.
Edition: 19(1): 5-15.
Issued Date: 2008.
Proton Therapy for Reirradiation of Progressive or Recurrent Chordoma.
Author: McDonald MW, Linton OR, Shah MV.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 87(5): 1107-14.
Issued Date: 2013.
Clinical Results of Proton Beam Therapy for Skull Base Chordoma.
Author: Igaki H, Tokuuye K, Okumura T, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 60(4): 1120-6.
Issued Date: 2004.
Proton therapy for skull base chordoma: an outcomes study from the University of Florida Proton Therapy Institute.
Author: Deraniyagala RL, Yeung D, Mendenhall WM, et al.
Journal: J Neurol Burg B Skull Base.
Edition: 75(1): 53-7.
Issued Date: 2014.
Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.
Author: Chen YL, Liebsch N, Kobayashi W, et al.
Journal: Spine.
Edition: 38(15):e930-6.
Issued Date: 2013.
Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: fi rst long-term report.
Author: Ares C, Hug EB, Lomax AJ, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 75(4): 1111-1118.
Issued Date: 2009.
Proton stereotactic radiosurgery for the treatment of benign meningiomas.
Author: Halasz LM, Bussiere MR, Dennis ER et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 81(5):1428-35.
Issued Date: 2011 Dec 1.
Fractionated proton radiotherapy for benign cavernous sinus meningiomas.
Author: Slater JD1, Loredo LN, Chung A et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 83(5):e633-7.
Issued Date: 2012.
Long term results of stereotactic proton beam radiotherapy for acoustic neuromas.
Author: Vernimmen FJ, Mohamed Z, Slabbert JP, et al.
Journal: Radiother Oncol.
Edition: 90(2): 208-12.
Issued Date: 2009.
Proton Beam Radiosurgery for Vestibular Schwannoma: Tumor control and cranial nerve toxicity.
Author: Weber, DC, Chan AW, Bussiere MR, et al.
Journal: Neurosurgery.
Edition: 53(3): 577-88.
Issued Date: 2003.
Fractionated, stereotactic proton beam treatment of cerebral arteriovenous malformations.
Author: Silander H, Pellettieri L, Enblad P, et al.
Journal: Acta Neurol Scand.
Edition: 109(2):85-90.
Issued Date: 2004.
Proton-beam therapy for olfactory neuroblastoma.
Author: Nishimura H, Ogino T, Kawashima M, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 68(3): 758-62.
Issued Date: 2007.
First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Post-operative Proton Therapy for Chordomas and Chondrosarcomas of the Spine: Adjuvant vs.
Author: Holliday EB, Mitra HS, Somerson JS et al.
Journal: Salvage Radiation Therapy. Spine (Phila Pa 1976).
Edition:
Issued Date: 2015 Jan 23.
Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques.
Author: Kahn J, Loeffler JS, Niemierko A et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 81(1):232-8.
Issued Date: 2011.
Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.
Author: Morimoto K, Demizu Y, Hashimoto N et al.
Journal: Jpn J Clin Oncol.
Edition: 44(5):428-34.
Issued Date: 2014.
Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy.
Author: McDonald MW, Linton OR, Calley CS.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 91(2):261-7.
Issued Date: 2015.
Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option.
Author: Mock U, Georg D, Solkner L et al.
Journal: Radiother Oncol.
Edition: 111(3):451-6.
Issued Date: 2014.
Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Author: Grosshans DR, Zhu XR, Melancon A et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 90(3):540-6.
Issued Date: 2014.
Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy.
Author: Maquilan G, Grover S, Alonso-Basanta M et al.
Journal: Am J Clin Oncol.
Edition: 37(5):438-43.
Issued Date: 2014.
Dose escalation with proton radiation therapy for high-grade meningiomas.
Author: Chan AW, Bernstein KD, Adams JA et al.
Journal: Technol Cancer Res Treat.
Edition: 11(6):607-14.
Issued Date: 2012.
A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
Author: Dennis ER, Bussiere MR, Niemierko A et al.
Journal: Technol Cancer Res Treat.
Edition: 12(1):1-9.
Issued Date: 2013.
Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites.
Author: Kainz K, Firat S, Wilson JF et al.
Journal: Phys Med Bio.
Edition: 60(6):2167-2177.
Issued Date: 2015.
First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Author: Hauswald H, Rieken S, Ecker S et al.
Journal: Radiat Oncol.
Edition: 7:189. doi: 10.1186/1748-717X-7-189.
Issued Date: 2012 Nov 9.
Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.
Author: Matsuda M, Yamamoto T, Ishikawa E et al.
Journal: Br J Radiol.
Edition: 84:S54-60.
Issued Date: 2011.
Particle radiation therapy using proton and heavier ion beams.
Author: Schulz-Ertner D, Tsujii H.
Journal: J Clin Oncol.
Edition: 25(8):953-64.
Issued Date: 2007.
Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
Author: Rieken S, Habermehl D, Nikoghosyan A et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 81(5):e793-801.
Issued Date: 2011.
Proton therapy for low-grade gliomas: Results from a prospective trial.
Author: Shih HA, Sherman JC, Nachtigall LB et al.
Journal: Cancer.
Edition: doi: 10.1002/cncr.29237.
Issued Date: 2015.
Proton therapy in chordoma of the base of the skull: a systematic review.
Author: Amichetti M, Cianchetti M, Amelio D et al.
Journal: Neurosurg Rev.
Edition: 32(4):403-16.
Issued Date: 2009.
Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.
Author: Combs SE, Kessel K, Habermehl, et al.
Journal: Acta Oncol.
Edition: 52(7):1504-1509.
Issued Date: 2013.
Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Author: Weber DC, Schneider R, Goitein G, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 83(3):865-871.
Issued Date: 2012.
Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
Author: Mizumoto M, Tsubio K, Igaki H, et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 77(1): 98-105.
Issued Date: 2010.
Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
Author: Fitzek MM, Thornton AF, Rabinov JD et al.
Journal: J Neurosurg.
Edition: 91(2):251-60.
Issued Date: 1999.
Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Author: Iuchi T, Hatano K, Kodama T et al.
Journal: Int J Radiat Oncol Biol Phys.
Edition: 88(4):793-800.
Issued Date: 2014.
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.